Table III.
Variable | HR | 95% CI | P-value |
---|---|---|---|
Non-cCR | 2.27 | 0.87–5.94 | 0.0955 |
Primary stage IV | 1.14 | 0.64–2.03 | 0.6495 |
Metastatic sites no. ≥3 | 1.79 | 0.95–3.36 | 0.0714 |
Visceral sites no. ≥2 | 1.07 | 0.62–1.86 | 0.7968 |
NLR≥1.90 | 1.75 | 1.09–2.85 | 0.0218 |
Bold type indicates a statistically significant difference (P<0.05). HR, hazard ratio; CI, confidence interval; cCR, clinical complete response; NLR, neutrophil-lymphocyte ratio.